Sonny Batra, MD

Assistant Professor, Radiation Oncology

Sonny  Batra
150 S Huntington Avenue


Dr. Batra, MD is a practicing Radiation Oncologist in Jamaica Plain, MA. Dr. Batra graduated from Stanford University School of Medicine in 2010 and has been in practice for 9 years. He completed a residency at Hospital of the University of Pennsylvania. He currently practices at Boston VAMC and is affiliated with Beth Israel Deaconess Medical Center.

Other Positions

  • VA Boston Healthcare System


  • Stanford University, MD
  • University of California, Berkeley, BS


  • Published on 5/4/2016

    Swisher-McClure S, Yin L, Rosen M, Batra S, Berman AT, Both S, Vapiwala N. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation. Acta Oncol. 2016 Jul; 55(7):828-33. PMID: 27145164.

    Read at: PubMed
  • Published on 3/17/2016

    Armstrong CL, Fisher MJ, Li Y, Lustig RA, Belasco JB, Minturn JE, Hill-Kayser CE, Batra S, Phillips PC. Neuroplastic Response After Radiation Therapy for Pediatric Brain Tumors: A Pilot Study. Int J Radiat Oncol Biol Phys. 2016 Jul 01; 95(3):991-998. PMID: 27302514.

    Read at: PubMed
  • Published on 3/26/2015

    Fang P, Batra S, Hollander AB, Lin A, Hill-Kayser CE, Levin LM, Mupparapu M, Thompson RF. Development and evaluation of a standardized method and atlas for contouring primary and permanent dentition. Dentomaxillofac Radiol. 2015; 44(7):20150034. PMID: 25812046.

    Read at: PubMed
  • Published on 3/19/2015

    Lin LL, Vennarini S, Dimofte A, Ravanelli D, Shillington K, Batra S, Tochner Z, Both S, Freedman G. Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer. Acta Oncol. 2015 Jul; 54(7):1032-9. PMID: 25789715.

    Read at: PubMed
  • Published on 8/30/2011

    Matsumoto S, Batra S, Saito K, Yasui H, Choudhuri R, Gadisetti C, Subramanian S, Devasahayam N, Munasinghe JP, Mitchell JB, Krishna MC. Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res. 2011 Oct 15; 71(20):6350-9. PMID: 21878530.

    Read at: PubMed
  • Published on 10/6/2009

    Matsumoto S, Yasui H, Batra S, Kinoshita Y, Bernardo M, Munasinghe JP, Utsumi H, Choudhuri R, Devasahayam N, Subramanian S, Mitchell JB, Krishna MC. Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI. Proc Natl Acad Sci U S A. 2009 Oct 20; 106(42):17898-903. PMID: 19815528.

    Read at: PubMed
  • Published on 2/24/2006

    Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun. 2006 Apr 21; 342(4):1228-32. PMID: 16516163.

    Read at: PubMed
  • Published on 11/1/2005

    Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, Reguart N, Batra S, Mikami I, Jablons DM. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer. 2005 Nov 01; 117(2):326-32. PMID: 15900580.

    Read at: PubMed
  • Published on 7/1/2005

    He B, Barg RN, You L, Xu Z, Reguart N, Mikami I, Batra S, Rosell R, Jablons DM. Wnt signaling in stem cells and non-small-cell lung cancer. Clin Lung Cancer. 2005 Jul; 7(1):54-60. PMID: 16098245.

    Read at: PubMed
  • Published on 5/24/2005

    Mikami I, You L, He B, Xu Z, Batra S, Lee AY, Mazieres J, Reguart N, Uematsu K, Koizumi K, Jablons DM. Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer. 2005 May 24; 5:53. PMID: 15913453.

    Read at: PubMed

View 2 more publications: View full profile at BUMC

View all profiles